157 related articles for article (PubMed ID: 8573126)
1. Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors.
Siegrist W; Willard DH; Wilkison WO; Eberle AN
Biochem Biophys Res Commun; 1996 Jan; 218(1):171-5. PubMed ID: 8573126
[TBL] [Abstract][Full Text] [Related]
2. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
3. Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti.
Siegrist W; Drozdz R; Cotti R; Willard DH; Wilkison WO; Eberle AN
J Recept Signal Transduct Res; 1997; 17(1-3):75-98. PubMed ID: 9029482
[TBL] [Abstract][Full Text] [Related]
4. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor.
Eberle AN; Bódi J; Orosz G; Süli-Vargha H; Jäggin V; Zumsteg U
J Recept Signal Transduct Res; 2001 Feb; 21(1):25-45. PubMed ID: 11693171
[TBL] [Abstract][Full Text] [Related]
5. Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene.
Chluba-de Tapia J; Bagutti C; Cotti R; Eberle AN
J Cell Sci; 1996 Aug; 109 ( Pt 8)():2023-30. PubMed ID: 8856498
[TBL] [Abstract][Full Text] [Related]
6. Melanocortin receptors and antagonists regulate pigmentation and body weight.
Jordan SA; Jackson IJ
Bioessays; 1998 Aug; 20(8):603-6. PubMed ID: 9780833
[TBL] [Abstract][Full Text] [Related]
7. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
Hintermann E; Tanner H; Talke-Messerer C; Schlumberger S; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 2001 Feb; 21(1):93-116. PubMed ID: 11693176
[TBL] [Abstract][Full Text] [Related]
8. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells.
Mountjoy KG; Kong PL; Taylor JA; Willard DH; Wilkison WO
Physiol Genomics; 2001 Feb; 5(1):11-9. PubMed ID: 11161002
[TBL] [Abstract][Full Text] [Related]
9. Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis.
Hunt G; Thody AJ
J Endocrinol; 1995 Nov; 147(2):R1-4. PubMed ID: 7490543
[TBL] [Abstract][Full Text] [Related]
10. Betulin binds to melanocortin receptors and antagonizes alpha-melanocyte stimulating hormone induced cAMP generation in mouse melanoma cells.
Muceniece R; Saleniece K; Riekstina U; Krigere L; Tirzitis G; Ancans J
Cell Biochem Funct; 2007; 25(5):591-6. PubMed ID: 17605140
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
[TBL] [Abstract][Full Text] [Related]
12. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
[TBL] [Abstract][Full Text] [Related]
13. Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone.
Graham A; Wakamatsu K; Hunt G; Ito S; Thody AJ
Pigment Cell Res; 1997 Oct; 10(5):298-303. PubMed ID: 9359625
[TBL] [Abstract][Full Text] [Related]
14. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line.
Boston BA; Cone RD
Endocrinology; 1996 May; 137(5):2043-50. PubMed ID: 8612546
[TBL] [Abstract][Full Text] [Related]
15. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of melanogenesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone.
Lee J; Jung E; Lee J; Huh S; Boo YC; Hyun CG; Kim YS; Park D
Br J Dermatol; 2007 Aug; 157(2):242-8. PubMed ID: 17650175
[TBL] [Abstract][Full Text] [Related]
17. Agouti signaling protein and other factors modulating differentiation and proliferation of immortal melanoblasts.
Sviderskaya EV; Hill SP; Balachandar D; Barsh GS; Bennett DC
Dev Dyn; 2001 Aug; 221(4):373-9. PubMed ID: 11500974
[TBL] [Abstract][Full Text] [Related]
18. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes.
Martínez-Esparza M; Solano F; García-Borrón JC
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):991-1000. PubMed ID: 10644003
[TBL] [Abstract][Full Text] [Related]
19. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes.
Abdel-Malek ZA; Scott MC; Furumura M; Lamoreux ML; Ollmann M; Barsh GS; Hearing VJ
J Cell Sci; 2001 Mar; 114(Pt 5):1019-24. PubMed ID: 11181184
[TBL] [Abstract][Full Text] [Related]
20. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin.
Suzuki I; Tada A; Ollmann MM; Barsh GS; Im S; Lamoreux ML; Hearing VJ; Nordlund JJ; Abdel-Malek ZA
J Invest Dermatol; 1997 Jun; 108(6):838-42. PubMed ID: 9182807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
